CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high ...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that physicians at all of the 17 “Honor Roll” hospitals and all of the 50 “Best Cardiology ...

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT CHELMSFORD, ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).

CHELMSFORD, Mass., December 02, 2025--(BUSINESS WIRE)--ZOLL ®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the complete U.S. rollout of its next ...

Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US. The latest device is the fifth LifeVest WCD, ...

A phase 3 trial of Zoll Medical’s LifeVest has missed its primary endpoint. The study found that people who started using the wearable defibrillator the week after they had a heart attack were as ...

CHELMSFORD, Mass., December 19, 2025--(BUSINESS WIRE)--ZOLL ®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the complete U.S. rollout of its next generation garment for the LifeVest® wearable ...

Backed by decades of continuous innovation informed by patient feedback, LifeVest continues to set the standard in the WCD market. LifeVest delivers highly effective, safe therapy for patients at risk ...